Divergent synthesis of biflavonoids yields novel inhibitors of the aggregation of amyloid β (1–42)
TH Sum, TJ Sum, S Collins, WRJD Galloway… - Organic & …, 2017 - pubs.rsc.org
Biflavonoids are associated with a variety of biologically useful properties. However,
synthetic biflavonoids are poorly explored within drug discovery. There is considerable …
synthetic biflavonoids are poorly explored within drug discovery. There is considerable …
Gelatin as a potential inhibitor of insulin amyloid fibril formation
J Jayamani, G Shanmugam - ChemistrySelect, 2016 - Wiley Online Library
Direct inhibition of amyloid fibrillation, the primary cause of many neurodegenerative
diseases, using natural and synthetic molecules is one of the therapeutic strategies to …
diseases, using natural and synthetic molecules is one of the therapeutic strategies to …
Kolaflavanone, a biflavonoid derived from medicinal plant Garcinia, is an inhibitor of mitotic kinesin Eg5
Mitotic kinesin Eg5 remains a validated target in antimitotic therapy because of its essential
role in the formation and maintenance of bipolar mitotic spindles. Although numerous Eg5 …
role in the formation and maintenance of bipolar mitotic spindles. Although numerous Eg5 …
Structural features of small molecule amyloid-beta self-assembly inhibitors
The role of various structural features, namely basic scaffolds and substituents of small
molecule inhibitors of the self-assembly of amyloid-beta (Aβ) peptide, a key process in …
molecule inhibitors of the self-assembly of amyloid-beta (Aβ) peptide, a key process in …
Inhibition of β-amyloid Aggregation of Ugni molinae Extracts
D Jara-Moreno, AL Riveros, A Barriga… - Current …, 2020 - ingentaconnect.com
The β-amyloid peptide (1-42) is a molecule capable of aggregating into neurotoxic
structures that have been implicated as potential etiological factors of Alzheimer's Disease …
structures that have been implicated as potential etiological factors of Alzheimer's Disease …
Development of a brain-permeable peptide nanofiber that prevents aggregation of Alzheimer pathogenic proteins
N Tanaka, M Okuda, T Nishigaki, N Tsuchiya… - PLOS …, 2020 - journals.plos.org
Alzheimer's disease (AD) is proposed to be induced by abnormal aggregation of amyloidβ in
the brain. Here, we designed a brain-permeable peptide nanofiber drug from a fragment of …
the brain. Here, we designed a brain-permeable peptide nanofiber drug from a fragment of …
Modeling of chemical inhibition from amyloid protein aggregation kinetics
JA Vázquez - BMC Pharmacology and Toxicology, 2014 - Springer
Backgrounds The process of amyloid proteins aggregation causes several human
neuropathologies. In some cases, eg. fibrillar deposits of insulin, the problems are …
neuropathologies. In some cases, eg. fibrillar deposits of insulin, the problems are …
Dehydroabietylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease
Dehydroabietylamine derivatives have been reported to eliminate the superoxide anion
(O2−˙) and 1, 1-dipheny-2-picrylhydrazyl radicals. In this work, several dehydroabietylamine …
(O2−˙) and 1, 1-dipheny-2-picrylhydrazyl radicals. In this work, several dehydroabietylamine …